GE HealthCare Technologies Inc. $GEHC Shares Acquired by Fjarde AP Fonden Fourth Swedish National Pension Fund

Fjarde AP Fonden Fourth Swedish National Pension Fund increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 34.9% during the 1st quarter, HoldingsChannel reports. The firm owned 117,343 shares of the company’s stock after acquiring an additional 30,388 shares during the period. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in GE HealthCare Technologies were worth $8,352,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in GEHC. Auto Owners Insurance Co grew its stake in GE HealthCare Technologies by 9,525.4% during the 4th quarter. Auto Owners Insurance Co now owns 33,982,610 shares of the company’s stock worth $278,725,000 after buying an additional 33,629,559 shares during the last quarter. Norges Bank bought a new stake in GE HealthCare Technologies in the fourth quarter valued at $596,024,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new position in shares of GE HealthCare Technologies during the fourth quarter valued at $533,655,000. Capital Research Global Investors boosted its holdings in shares of GE HealthCare Technologies by 25.0% during the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company’s stock valued at $1,875,400,000 after acquiring an additional 4,998,154 shares during the period. Finally, Cynosure Group LLC grew its position in shares of GE HealthCare Technologies by 21,045.4% during the fourth quarter. Cynosure Group LLC now owns 4,365,462 shares of the company’s stock worth $358,055,000 after acquiring an additional 4,344,817 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insiders Place Their Bets

In related news, Director Rodney F. Hochman acquired 1,618 shares of the firm’s stock in a transaction dated Tuesday, May 12th. The stock was acquired at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the completion of the acquisition, the director directly owned 1,618 shares of the company’s stock, valued at approximately $100,364.54. The trade was a ∞ increase in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO James Saccaro acquired 3,310 shares of the stock in a transaction that occurred on Friday, May 1st. The shares were bought at an average price of $60.60 per share, for a total transaction of $200,586.00. Following the purchase, the chief financial officer directly owned 87,471 shares of the company’s stock, valued at approximately $5,300,742.60. This trade represents a 3.93% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Over the last ninety days, insiders purchased 21,847 shares of company stock valued at $1,361,355. 0.36% of the stock is currently owned by insiders.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $65.57 on Friday. The stock has a market cap of $29.83 billion, a P/E ratio of 15.69, a P/E/G ratio of 1.78 and a beta of 0.72. The firm’s 50-day simple moving average is $63.70 and its 200 day simple moving average is $73.29. GE HealthCare Technologies Inc. has a fifty-two week low of $58.75 and a fifty-two week high of $89.77. The company has a quick ratio of 0.95, a current ratio of 1.22 and a debt-to-equity ratio of 0.95.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The company had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The business’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. Equities analysts expect that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is currently 3.35%.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Piper Sandler cut their price objective on shares of GE HealthCare Technologies from $88.00 to $74.00 in a research report on Thursday, April 30th. Evercore set a $80.00 target price on shares of GE HealthCare Technologies in a research report on Thursday, April 30th. Citigroup dropped their price target on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a research note on Thursday, April 30th. Barclays cut their price target on GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. Finally, Stifel Nicolaus set a $80.00 price objective on GE HealthCare Technologies in a research report on Wednesday, April 29th. Ten equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $80.20.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.